Design a rational combination therapy strategy for chronic HIV infection that uses complementary mechanisms to reduce viral load and delay resistance. Which combination is best and why?

A regimen combining nucleoside reverse transcriptase inhibitors (e.g., tenofovir), a protease inhibitor (e.g., ritonavir-boosted), and an integrase inhibitor, because targeting multiple, virus-specific enzymes reduces replication, limits the emergence of resistant strains, and impairs maturation at different steps.

Use a single high-dose protease inhibitor continuously without other agents, because high concentrations will permanently bind all proteases and no resistance mechanisms exist for protease inhibitors.

Combine acyclovir with oseltamivir to target both DNA and RNA polymerases simultaneously, ensuring all possible viral genomes are targeted regardless of the pathogen responsible for symptoms.

Alternate daily between interferon-alpha and neuraminidase inhibitors to create an unpredictable environment for the virus, relying on host immune hyperstimulation to eradicate HIV in the first week of treatment.